Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.975 USD | +4.45% | +3.31% | +117.37% |
Evolution of the average Target Price on ADMA Biologics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering ADMA Biologics, Inc.
Cantor Fitzgerald | |
HC Wainwright | |
Mizuho Securities | |
Raymond James | |
Chardan |
EPS Revisions
- Stock Market
- Equities
- ADMA Stock
- Consensus ADMA Biologics, Inc.